vs
Side-by-side financial comparison of Cronos Group Inc. (CRON) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.
Cronos Group Inc. is the larger business by last-quarter revenue ($44.5M vs $31.4M, roughly 1.4× Ponce Financial Group, Inc.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -4.1%, a 40.4% gap on every dollar of revenue. On growth, Cronos Group Inc. posted the faster year-over-year revenue change (47.0% vs 37.6%). Ponce Financial Group, Inc. produced more free cash flow last quarter ($54.6M vs $9.7M). Over the past eight quarters, Cronos Group Inc.'s revenue compounded faster (32.7% CAGR vs 23.7%).
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.
CRON vs PDLB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.5M | $31.4M |
| Net Profit | $-1.8M | $10.1M |
| Gross Margin | 36.4% | — |
| Operating Margin | -16.8% | 43.6% |
| Net Margin | -4.1% | 36.3% |
| Revenue YoY | 47.0% | 37.6% |
| Net Profit YoY | -104.2% | 245.6% |
| EPS (diluted) | $-0.01 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.5M | $31.4M | ||
| Q3 25 | $36.3M | $26.7M | ||
| Q2 25 | $33.5M | $26.5M | ||
| Q1 25 | $32.3M | $24.6M | ||
| Q4 24 | $30.3M | $22.8M | ||
| Q3 24 | $34.3M | $20.2M | ||
| Q2 24 | $27.8M | $20.2M | ||
| Q1 24 | $25.3M | $20.5M |
| Q4 25 | $-1.8M | $10.1M | ||
| Q3 25 | $26.0M | $6.5M | ||
| Q2 25 | $-39.7M | $6.1M | ||
| Q1 25 | $6.1M | $6.0M | ||
| Q4 24 | $43.7M | $2.9M | ||
| Q3 24 | $8.3M | $2.4M | ||
| Q2 24 | $-8.8M | $3.2M | ||
| Q1 24 | $-2.2M | $2.4M |
| Q4 25 | 36.4% | — | ||
| Q3 25 | 50.4% | — | ||
| Q2 25 | 43.4% | — | ||
| Q1 25 | 42.6% | — | ||
| Q4 24 | 35.7% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 22.7% | — | ||
| Q1 24 | 17.7% | — |
| Q4 25 | -16.8% | 43.6% | ||
| Q3 25 | -1.4% | 32.8% | ||
| Q2 25 | -15.9% | 30.2% | ||
| Q1 25 | -12.6% | 32.5% | ||
| Q4 24 | -37.5% | 19.6% | ||
| Q3 24 | -98.2% | 15.2% | ||
| Q2 24 | -56.1% | 21.8% | ||
| Q1 24 | -63.1% | 18.3% |
| Q4 25 | -4.1% | 36.3% | ||
| Q3 25 | 71.4% | 24.3% | ||
| Q2 25 | -118.7% | 23.0% | ||
| Q1 25 | 19.0% | 24.2% | ||
| Q4 24 | 144.3% | 14.1% | ||
| Q3 24 | 24.4% | 12.1% | ||
| Q2 24 | -31.5% | 15.8% | ||
| Q1 24 | -8.9% | 11.8% |
| Q4 25 | $-0.01 | $0.43 | ||
| Q3 25 | $0.07 | $0.27 | ||
| Q2 25 | $-0.10 | $0.25 | ||
| Q1 25 | $0.02 | $0.25 | ||
| Q4 24 | $0.12 | $0.11 | ||
| Q3 24 | $0.02 | $0.10 | ||
| Q2 24 | $-0.02 | $0.14 | ||
| Q1 24 | $-0.01 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $831.8M | $126.2M |
| Total DebtLower is stronger | — | $596.1M |
| Stockholders' EquityBook value | $1.1B | $541.5M |
| Total Assets | $1.2B | $3.2B |
| Debt / EquityLower = less leverage | — | 1.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $831.8M | $126.2M | ||
| Q3 25 | $824.2M | $146.6M | ||
| Q2 25 | $834.4M | $126.6M | ||
| Q1 25 | $837.8M | $129.9M | ||
| Q4 24 | $858.8M | $139.8M | ||
| Q3 24 | $862.0M | $155.8M | ||
| Q2 24 | $848.2M | $103.2M | ||
| Q1 24 | $855.1M | $134.7M |
| Q4 25 | — | $596.1M | ||
| Q3 25 | — | $521.1M | ||
| Q2 25 | — | $536.1M | ||
| Q1 25 | — | $521.1M | ||
| Q4 24 | — | $596.1M | ||
| Q3 24 | — | $580.4M | ||
| Q2 24 | — | $680.4M | ||
| Q1 24 | — | $680.4M |
| Q4 25 | $1.1B | $541.5M | ||
| Q3 25 | $1.1B | $529.8M | ||
| Q2 25 | $1.1B | $521.1M | ||
| Q1 25 | $1.1B | $513.9M | ||
| Q4 24 | $1.1B | $505.5M | ||
| Q3 24 | $1.1B | $504.6M | ||
| Q2 24 | $1.1B | $497.7M | ||
| Q1 24 | $1.1B | $493.7M |
| Q4 25 | $1.2B | $3.2B | ||
| Q3 25 | $1.2B | $3.2B | ||
| Q2 25 | $1.2B | $3.2B | ||
| Q1 25 | $1.2B | $3.1B | ||
| Q4 24 | $1.2B | $3.0B | ||
| Q3 24 | $1.2B | $3.0B | ||
| Q2 24 | $1.1B | $2.8B | ||
| Q1 24 | $1.1B | $2.8B |
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 1.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.8M | $55.6M |
| Free Cash FlowOCF − Capex | $9.7M | $54.6M |
| FCF MarginFCF / Revenue | 21.8% | 173.9% |
| Capex IntensityCapex / Revenue | 4.8% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 5.48× |
| TTM Free Cash FlowTrailing 4 quarters | $149.0K | $74.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.8M | $55.6M | ||
| Q3 25 | $13.3M | $1.4M | ||
| Q2 25 | $2.8M | $6.2M | ||
| Q1 25 | $-2.1M | $13.1M | ||
| Q4 24 | $7.7M | $7.2M | ||
| Q3 24 | $11.6M | $-14.6M | ||
| Q2 24 | $1.7M | $-2.6M | ||
| Q1 24 | $-2.2M | $1.5M |
| Q4 25 | $9.7M | $54.6M | ||
| Q3 25 | $8.8M | $786.0K | ||
| Q2 25 | $-1.0M | $5.9M | ||
| Q1 25 | $-17.4M | $12.9M | ||
| Q4 24 | $4.2M | $4.5M | ||
| Q3 24 | $5.2M | $-15.0M | ||
| Q2 24 | $1.0M | $-2.6M | ||
| Q1 24 | $-3.9M | $-315.0K |
| Q4 25 | 21.8% | 173.9% | ||
| Q3 25 | 24.3% | 2.9% | ||
| Q2 25 | -3.0% | 22.4% | ||
| Q1 25 | -53.8% | 52.6% | ||
| Q4 24 | 13.8% | 19.7% | ||
| Q3 24 | 15.1% | -74.1% | ||
| Q2 24 | 3.7% | -13.0% | ||
| Q1 24 | -15.5% | -1.5% |
| Q4 25 | 4.8% | 3.1% | ||
| Q3 25 | 12.3% | 2.3% | ||
| Q2 25 | 11.5% | 1.0% | ||
| Q1 25 | 47.3% | 0.6% | ||
| Q4 24 | 11.7% | 11.9% | ||
| Q3 24 | 18.7% | 2.0% | ||
| Q2 24 | 2.6% | 0.3% | ||
| Q1 24 | 6.8% | 8.7% |
| Q4 25 | — | 5.48× | ||
| Q3 25 | 0.51× | 0.21× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | -0.34× | 2.20× | ||
| Q4 24 | 0.18× | 2.46× | ||
| Q3 24 | 1.39× | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
PDLB
Segment breakdown not available.
